These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2586596)

  • 1. Biotechnology: Celltech to change hands?
    Newark P
    Nature; 1989 Nov; 342(6248):334. PubMed ID: 2586596
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploitation of biotechnology in a smaller company.
    Fairtlough GH
    Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):589-97. PubMed ID: 2573092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK biotechnology. A public for Celltech?
    Newmark P
    Nature; 1983 Jul 21-27; 304(5923):202. PubMed ID: 6191224
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology. Little apparent interest in Celltech sell-off.
    Aldhous P
    Nature; 1990 May; 345(6271):102. PubMed ID: 2336099
    [No Abstract]   [Full Text] [Related]  

  • 5. Celltech undeterred by crash of '87.
    Wenz C
    Nature; 1987 Nov 5-11; 330(6143):5. PubMed ID: 3670393
    [No Abstract]   [Full Text] [Related]  

  • 6. Celltech, Chiroscience fire merger gun.
    Hodgson J
    Nat Biotechnol; 1999 Aug; 17(8):741-2. PubMed ID: 10429226
    [No Abstract]   [Full Text] [Related]  

  • 7. Celltech announces public offering.
    Ward M
    Nature; 1993 Nov; 366(6450):9. PubMed ID: 8232544
    [No Abstract]   [Full Text] [Related]  

  • 8. Imclone's next headache.
    Varchaver N
    Fortune; 2006 Sep; 154(6):35. PubMed ID: 17036725
    [No Abstract]   [Full Text] [Related]  

  • 9. Transatlantic merger creates potent hybrid in bioscience research.
    Ward M
    Nature; 1996 Nov; 384(6607):299. PubMed ID: 8934506
    [No Abstract]   [Full Text] [Related]  

  • 10. Network on Advanced Micro-Technologies for Microsurgery.
    Brett PN
    Int J Med Robot; 2007 Mar; 3():1-2. PubMed ID: 17441018
    [No Abstract]   [Full Text] [Related]  

  • 11. UK firms buy into drug design skills of US start-ups.
    Nature; 1995 Feb; 373(6513):372. PubMed ID: 7830777
    [No Abstract]   [Full Text] [Related]  

  • 12. Zeneca cuts seeds but enters genome technologies.
    Nature; 1994 Aug; 370(6489):406. PubMed ID: 8047152
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech industry faces new bottleneck.
    Garber K
    Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516
    [No Abstract]   [Full Text] [Related]  

  • 14. Spin-outs and incubators: philosophy and practice.
    Howard C
    Drug Discov Today; 2002 Aug; 7(16):837-9. PubMed ID: 12546939
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategic alliances in the Australian biotechnology industry. A comparative view.
    Scott-Kemmis D; Darling T; Stark P
    Aust J Biotechnol; 1988 Sep; 2(2):122-6. PubMed ID: 2485325
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of biotechnology.
    Dunnill P
    Biochem Soc Symp; 1983; 48():9-23. PubMed ID: 6571209
    [No Abstract]   [Full Text] [Related]  

  • 17. Leading biotechnology companies quit the IBA.
    Gershon D
    Nature; 1990 Apr; 344(6266):481. PubMed ID: 2320118
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing change in biotech: mergers and acquisitions.
    Rafferty MA
    Nat Biotechnol; 2007 Jun; 25(6):689-90. PubMed ID: 17557106
    [No Abstract]   [Full Text] [Related]  

  • 19. Partnerships between patients, medicine, and the biotechnology industry.
    Kent A; Tambuyzer E
    Nat Biotechnol; 1999 Oct; 17(10):935. PubMed ID: 10504676
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing dynamics of strategic alliances between US biotechnology firms and Japanese corporations and universities.
    Bullock WO; Dibner MD
    Trends Biotechnol; 1994 Oct; 12(10):397-400. PubMed ID: 7765385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.